Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Market for Biomarkers 2015-2020 - Focus on Cancer Markers, Cardiac Markers, Immunological Disease Markers & Infectious Disease Markers - Research and Markets

This image opens in the lightbox

News provided by

Research and Markets

16 May, 2016, 18:10 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, May 16, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others)" report to their offering.

Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. Biomarkers also have important roles in drug discovery and development.

The biomarker market is large, reflecting the large market for diagnostic tests based on these biomarkers, and also the ongoing efforts to discovery, validate, and commercialize new biomarkers. Growth in this market is fueled by factors that are fostering the growth of both the research and the diagnostics market. Market drivers and challenges are discussed in the report.

The large and growing biomarker market has attracted a lot of attention, and companies entering the market. Thus this has become a highly competitive market. The report profiles companies involved in the biomarkers market.

The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.

Key Topics Covered:

1 - Executive Summary

2 - Introduction

3 - Selected Technologies Used to identify & analyze Biomarkers

4 - Cancer Biomarkers

5 - Cardiovascular Disease Biomarkers

6 - Immunological Disease Biomarkers

7 - Infectious Disease Biomarkers

8 - Neurological Disease Biomarkers

9 - Novel Biomarkers for other diseases

10 - Deals

11 - Market Drivers and Challenge

12 - Biomarker Market Analysis

13 - Company Profiles: Biomarker Companies

  • 14M Genomics Ltd.
  • 20/20 GeneSystems, Inc
  • 23andMe, Inc.
  • A&G Pharmaceutical, Inc.
  • ACT Genomics Co., Ltd.
  • AESKU.DIAGNOSTICS
  • ALPCO
  • AXO Science
  • Abacus Diagnostica Oy
  • Abbott Laboratories
  • Abcodia Ltd.
  • Accelerate Diagnostics, Inc.
  • Acobiom
  • Acumen Pharmaceuticals, Inc.
  • Adaptive Biotechnologies Corporation
  • Adlyfe Inc.
  • Admera Health (A GENEWIZ Company)
  • Affymetrix, Inc.
  • Agena Bioscience Inc.
  • Agendia NV
  • Agilent Technologies Inc.
  • Alere Inc.
  • Almac Group Limited
  • Amarantus BioScience Holdings, Inc.
  • Ambry Genetics Corp.
  • Aperiomics, Inc.
  • ApoCell, Inc.
  • Applied Proteomics, Inc.
  • Associates of Cape Cod, Inc. (ACC)
  • Asuragen, Inc.
  • AsymmetRx Medical, Inc.
  • Athena Diagnostics, Inc. (A Quest Diagnostics Business)
  • Atlas Genetics Ltd
  • Atossa Genetics Inc.
  • Augurex Life Sciences Corp.
  • Augurix SA/Augurix Diagnostics
  • Avant Diagnostics, Inc. (Formerly Arrayit Diagnostics Inc.)
  • Axela, Inc
  • Axis-Shield Diagnostics, Ltd. (An Alere Company)
  • BG Medicine, Inc.
  • BIOUNIVERSA s.r.l.
  • Banyan Biomarkers, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • BioFire Diagnostics, LLC (Acquired by bioMérieux)
  • BioMarker Strategies
  • BioMedomics, Inc.
  • BioMosaics Inc.
  • BioPorto Diagnostics A/S
  • BioSystems International
  • Biocartis SA
  • Biocrates Life Sciences AG
  • Biodesix, Inc.
  • Biohit Oyj
  • Bioinnovation Solutions SA
  • Biotype Diagnostic GmbH
  • CD Diagnostics, Inc.
  • Cancer Genetics, Inc.
  • Caprion, Inc.
  • CardioDx, Inc.
  • CardioGenics Holdings Inc.
  • CareDx, Inc.
  • Caris Life Sciences
  • Castle Biosciences, Inc.
  • Cellmid Ltd.
  • Centogene AG
  • Cepheid
  • Chronix Biomedical, Inc.
  • Clarient Diagnostic Services, Inc. (A GE Healthcare Company; Being Acquired by
  • Company Overview
  • Courtagen Life Sciences, Inc.
  • Crescendo Bioscience (Subsidiary of Myriad Genetics)
  • Critical Diagnostics
  • Curetis AG
  • Cynvenio Biosystems, Inc.
  • DNA Electronics Ltd. (DNAe)
  • Dako A/S (An Agilent Company)
  • Danaher Corporation
  • DiaGenic ASA
  • Diadexus, Inc
  • Diagenics International Corporation
  • Diagenics SE
  • Diaxonhit
  • EntroGen, Inc.
  • Epic Sciences, Inc.
  • Epigenomics AG
  • Epinex Diagnostics, Inc.
  • Eutropics Pharmaceuticals
  • Exact Sciences Corporation
  • Exiqon A/S
  • Foundation Medicine, Inc.
  • Fujirebio Diagnositics, Inc.
  • Fujirebio Inc.
  • Gamma Therapeutics, Inc.
  • Genalyte, Inc.
  • GeneCentric Diagnostics, Inc.
  • GeneNews Limited and Innovative Diagnostic Laboratory
  • Genection, Inc. (An Invivoscribe Company)
  • GenomeDx Biosciences
  • Genomeon LLC
  • Genomic Health, Inc.
  • Genomic Vision
  • Genoptix (A Novartis Company)
  • Guardant Health, Inc.
  • HalioDx
  • Helomics Corporation
  • Hologic, Inc.
  • Illumina, Inc.
  • Immunexpress
  • Integrated Diagnostics, Inc.
  • Intrinsic LifeSciences
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • NeoGenomics, Inc.)
  • NeoGenomics, Inc./NeoGenomics Laboratories
  • OPKO Health, Inc./OPKO Diagnostics
  • ORGENTEC Diagnostika GmbH
  • Oncolab, Inc.
  • Oncospire Genomics
  • Orion Genomics
  • Ortho-Clinical Diagnostics
  • Oxford Gene Technology
  • Proteome Sciences plc
  • Psynova Neurotech Ltd.
  • QIAGEN N.V.
  • Quanterix Corporation
  • RENESE UG
  • Randox Laboratories Ltd
  • Rapid Pathogen Screening, Inc.
  • ReLIA Diagnostics, Inc.
  • Recent Revenue History and Other Financial Information
  • Roche
  • Siemens Healthcare Diagnostics
  • Sysmex Corporation
  • The Binding Site Group Ltd.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Ventana Medical Systems, Inc. (Member of the Roche Group)
  • Wako Pure Chemical Industries, Ltd.,
  • XRGenomics LTD
  • ZEUS Scientific, Inc.
  • bioMérieux SA
  • bioTheranostics, Inc. (A bioMérieux Company)
  • deCODE genetics

For more information visit http://www.researchandmarkets.com/research/dvxsvq/the_global_market

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Media Contact:

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.